EUVIMEDEUVIMED entdecken
Open Access

Effect of nonsteroidal anti‐inflammatory drugs (aspirin and naproxen) on inflammation‐associated proteomic profiles in mouse plasma and prostate during TMPRSS2‐ERG (fusion)‐driven prostate carcinogenesis

Ram Raj Prasad, Neha Mishra, Rama Kant, Jennifer T Fox, Robert H Shoemaker, Chapla Agarwal, Komal Raina iD, Rajesh Agarwal iD

Molecular Carcinogenesis · 2024

DOI: 10.1002/mc.23718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2024. Verfasst von Ram Raj Prasad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora,…. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Carcinogenesis, Naproxen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCI HHS, Kevin and Lorie Haarberg Funds for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent preclinical studies have shown that the intake of nonsteroidal anti‐inflammatory drugs (NSAIDs) aspirin and naproxen could be an effective intervention strategy against TMPRSS2‐ERG fusion‐driven prostate tumorigenesis. Herein, as a follow‐up mechanistic study, employing TMPRSS2‐ERG (fusion) positive tumors and plasma from TMPRSS2‐ERG. Pten flox/flox mice, we profiled the stage specific proteomic changes (focused on inflammatory circulating and prostate tissue/tumor‐specific cytokines, chemokines, and growth factors/growth signaling‐associated molecules) that contribute to prostate cancer (PCa) growth and progression in the TMPRSS2‐ERG fusion‐driven mouse model of tumorigenesis. In addition, the association of the protective effects of NSAIDs (aspirin 1400 ppm and naproxen 400 ppm) with the modulation of these specific molecular pathways was determined. A sandwich Elisa based membrane array‐proteome profiler identifying 111 distinct signaling molecules was employed. Overall, the plasma and prostate tissue sample analyses identified 54 significant and differentially expressed cytokines, chemokines, and growth factors/growth signaling‐associated molecules between PCa afflicted mice ( TMPRSS2‐ERG. Pten flox/flox , age‐matched noncancerous controls, NSAIDs‐supplemented and no‐drug controls). Bioinformatic analysis of the array outcomes indicated that the protective effect of NSAIDs was associated with reduced expression of (a) tumor promoting inflammatory molecules (M‐CSF, IL‐33, CCL22, CCL12, CX3CL1, CHI3L1, and CD93), (b) growth factors‐ growth signaling‐associated molecules (Chemerin, FGF acidic, Flt‐3 ligand, IGFBP‐5, and PEDF), and (c) tumor microenvironment/stromal remodeling proteins MMP2 and MMP9. Overall, our findings corroborate the pathological findings that protective effects of NSAIDs in TMPSS2‐ERG fusion‐driven prostate tumorigenesis are associated with antiproliferative and anti‐inflammatory effects and possible modulation of the immune cell enriched microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalAspirinCarcinogenesisNaproxenOncogene FusionProstateProstatic NeoplasmsSerine EndopeptidasesTranscriptional Regulator ERGAnimalsMaleMiceCytokinesInflammationProteomicsPTEN PhosphohydrolaseNeoplasms, ExperimentalOncogene Proteins

Stichwörter der Autor:innen

NSAIDTMPRSS2‐ERG fusionaspirincytokinesnaproxenprostate cancer

Substanzen

Anti-Inflammatory Agents, Non-SteroidalAspirinCytokinesNaproxenPTEN PhosphohydrolaseSerine EndopeptidasesTranscriptional Regulator ERGERG protein, mouseOncogene ProteinsPten protein, mouse

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland, USA.
  • Department of Pharmaceutical Sciences, South Dakota State University, Brookings, South Dakota, USA.
  • University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

ORCID-Profile: Komal Raina, Rajesh Agarwal

Förderung

  • NCI NIH HHS
  • NCI HHS
  • Kevin and Lorie Haarberg Funds for Cancer Research

Zitieren

APA

Prasad, R. R., Mishra, N., Kant, R., Fox, J. T., Shoemaker, R. H., Agarwal, C., Raina, K., & Agarwal, R. (2024). Effect of nonsteroidal anti‐inflammatory drugs (aspirin and naproxen) on inflammation‐associated proteomic profiles in mouse plasma and prostate during TMPRSS2‐ERG (fusion)‐driven prostate carcinogenesis. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23718

Vancouver

Prasad RR, Mishra N, Kant R, Fox JT, Shoemaker RH, Agarwal C, et al. Effect of nonsteroidal anti‐inflammatory drugs (aspirin and naproxen) on inflammation‐associated proteomic profiles in mouse plasma and prostate during TMPRSS2‐ERG (fusion)‐driven prostate carcinogenesis. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23718

BibTeX
@article{Prasad2024,
  author = {Prasad, Ram Raj and Mishra, Neha and Kant, Rama and Fox, Jennifer T and Shoemaker, Robert H and Agarwal, Chapla and Raina, Komal and Agarwal, Rajesh},
  title = {Effect of nonsteroidal anti‐inflammatory drugs (aspirin and naproxen) on inflammation‐associated proteomic profiles in mouse plasma and prostate during TMPRSS2‐ERG (fusion)‐driven prostate carcinogenesis},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  doi = {10.1002/mc.23718}
}
Kostenlos starten →